Artivion | CRY - Ebit

Stock Price
37.51
Daily Change
-0.82 -2.14%
Monthly
-12.83%
Yearly
34.69%
Q1 Forecast
37.14

Artivion reported $1.14M in EBIT for its fiscal quarter ending in March of 2023.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Accuray USD 11.38M 12.71M Sep/2024
AngioDynamics USD -4.05M 1.54M Feb/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Mesa Laboratories USD 4.45M 2.5M Sep/2024
Orthofix International USD -18.9M 6.01M Sep/2024
Pfizer USD 4.65B 71M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -322K 2.13M Dec/2023
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 112.65M 44.3M Sep/2025
Terumo JPY 43.88B 1.21B Dec/2025
Trinity Biotech USD -10.02M 8.31M Dec/2024